<DOC>
	<DOCNO>NCT00716859</DOCNO>
	<brief_summary>To assess effectiveness latanoprost 0.005 % ophthalmic solution dose once-daily timolol 0.5 % dose twice-daily paediatric subject 18 year age diagnose glaucoma .</brief_summary>
	<brief_title>A Phase 3 Prospective , Randomized , Double-Masked , 12-Week , Parallel Group Study In Pediatric Subjects With Glaucoma .</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Male female 18 year age Diagnosis glaucoma IOP 22 mmHg least 1 eye Require surgery acute angle closure Have prior cyclodestructive procedure Have history ocular trauma surgery either eye within 3 month baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>36 Weeks</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>